Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gains Network (GNS) vs Enzyme (MLN) Price & Performance

Gains NetworkTrade
EnzymeTrade

Price performance (Past 24H)

Key statistics

Gains Network vs Enzyme — how do they compare? Gains Network trades at Rp11,488 (market cap Rp268,84M, Rp12,74M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Gains Network is far larger — about 2× Enzyme's market cap, and Gains Network's circulating supply is 23,4M GNS versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Gains Network for 46 Days and Enzyme for 28 Days on average.

GNSMLN
Market Cap
Rp268,84MRp134,13M
Volume (24h)
Rp12,74MRp104,56M
Circulating Supply
23,4M GNS3,3M MLN
Typical Hold Time
46 Days28 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gains Network

Gains Network (GNS) is currently trading at Rp11,540 with a market cap of Rp268.95 million, showing a bullish technical signal supported by moving averages. The token is positioned between key support at Rp10,872 and resistance at Rp11,014, with mixed oscillator readings. Recent on-chain activity indicates an average hold time of 46 days, suggesting moderate holder confidence. No major protocol upgrades or ecosystem developments have been reported recently, keeping fundamental drivers stable.

Overall outlook is cautiously optimistic due to technical strength, but investors should monitor resistance levels closely. Key opportunities include potential breakout above Rp11,156, while risks involve low liquidity and regulatory uncertainties in the crypto space. Major concerns include the token's small market cap amplifying volatility and limited exchange depth.

Enzyme

Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.

Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.

About Gains Network

Gains Network is developing gTrade, a liquidity-efficient, powerful, and user-friendly decentralized leveraged trading platform. The protocol revolves around the ecosystem's ERC20 utility token (GNS) and ERC721 utility token (NFTs). It is a DAO governed by the $GNS token with the goal to create DeFi products that bring revenue that can be distributed in a $GNS staking pool.

Read more on GNS

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN